INNV - Innovus Pharmaceuticals Inc -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Innovus Pharmaceuticals Inc
IPO Date: March 4, 2021
Sector: Healthcare
Industry: Medical Care Facilities
Market Cap: $1.24B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.23 | 3.44%
Avg Daily Range (30 D): $0.25 | 2.37%
Avg Daily Range (90 D): $0.29 | 2.81%
Institutional Daily Volume
Avg Daily Volume: .16M
Avg Daily Volume (30 D): .56M
Avg Daily Volume (90 D): .36M
Trade Size
Avg Trade Size (Sh.): 89
Avg Trade Size (Sh.) (30 D): 89
Avg Trade Size (Sh.) (90 D): 66
Institutional Trades
Total Institutional Trades: 162
Avg Institutional Trade: $2.19M
Avg Institutional Trade (30 D): $1.24M
Avg Institutional Trade (90 D): $1.19M
Avg Institutional Trade Volume: .14M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.8M
Avg Closing Trade (30 D): $1.38M
Avg Closing Trade (90 D): $1.26M
Avg Closing Volume: 176.65K
 
News
Sep 23, 2026 @ 12:46 AM
InnovAge Announces Pricing of Secondary Offering o...
Source: Na
Aug 27, 2026 @ 1:35 PM
HealthEquity (HQY) Q2 Earnings and Revenues Top Es...
Source: Na
Apr 21, 2026 @ 12:00 PM
InnovAge to Announce Fiscal Third Quarter 2026 Fin...
Source: Na
Dec 11, 2025 @ 9:43 PM
Court Approves $27M Cash Settlement in InnovAge Se...
Source: Cohen Milstein Sellers & Toll Pllc
Sep 9, 2025 @ 11:19 PM
InnovAge Revenue Jumps 11% in Fiscal Q4
Source: Motley Fool Markets Team
Financials
  TTM Q4 2026 FY 2026
Basic EPS $-.02 $.06 $-.02
Diluted EPS $-.02 $.06 $-.02
Revenue $989.71M $261.95M $989.71M
Gross Profit $227.76M $62.56M $227.76M
Net Income / Loss $-.68M $9.78M $-.68M
Operating Income / Loss $2.62M $10.15M $2.62M
Cost of Revenue $312.1M $83.65M $312.1M
Net Cash Flow $33.84M $2.36M $33.84M
PE Ratio    
Splits
Mar 18, 2019 1:105